Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kayu Tanaka"'
Autor:
Yuki Katsumata, Yoshihide Kawasaki, Kayu Tanaka, Daisuke Nakayama, Hiromichi Katayama, Shuichi Shimada, Yohei Satake, Takuma Sato, Naoki Kawamorita, Shinichi Yamashita, Testuya Sato, Kosuke Shoji, Koji Mitsuzuka, Akihiro Ito
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 3, Pp 1522-1529 (2021)
Here, we discuss the safety and management of adverse events associated with pembrolizumab plus axitinib combination therapy for metastatic renal cell carcinoma in patients on hemodialysis. A 76-year-old man was diagnosed with cT3aN0M0 renal cell car
Externí odkaz:
https://doaj.org/article/f836686a18da49219a96dc9f58f4a191
Publikováno v:
Journal of Nephropathology, Vol 5, Iss 2, Pp 72-78 (2016)
Background:The relationship between hematuria and histological lesions, the effect of hematuria on response to steroid therapy, and the outcome in patients with immunoglobulin A nephropathy (IgAN) remain undetermined. Objectives: The aim of this stud
Externí odkaz:
https://doaj.org/article/dd7768c7892c4c18b30f53eb9a9b6e1e
Autor:
Takahito Moriyama, Kayu Tanaka, Chihiro Iwasaki, Yasuko Oshima, Ayami Ochi, Hiroshi Kataoka, Mitsuyo Itabashi, Takashi Takei, Keiko Uchida, Kosaku Nitta
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e91756 (2014)
BACKGROUND: Little is known about the long-term prognosis of patients with IgA nephropathy (IgAN). METHODS: This retrospective cohort analysis evaluated clinical and histological findings at the time of renal biopsy, initial treatment, patient outcom
Externí odkaz:
https://doaj.org/article/b773eaa0f1ca419ea3b6f94c9e56f032
Publikováno v:
Journal of Nephropathology
Background:The relationship between hematuria and histological lesions, the effect of hematuria on response to steroid therapy, and the outcome in patients with immunoglobulin A nephropathy (IgAN) remain undetermined. Objectives: The aim of this stud
Publikováno v:
Clinical and Experimental Nephrology. 19:815-821
The effects of hematuria on the outcome of IgA nephropathy (IgAN) remain unknown and treatment of IgAN with severe hematuria is controversial. Eighty-eight IgAN patients with proteinuria
Autor:
Mitsuyo Itabashi, Takashi Takei, Chihiro Iwasaki, Ken Tsuchiya, Ayami Ochi, Takahito Moriyama, Ari Shimizu, Kayu Tanaka, Syunji Shiohira, Keiko Uchida, Kosaku Nitta
Publikováno v:
Internal Medicine. 52:193-199
OBJECTIVE The beneficial effects of renin-angiotensin-aldosterone system inhibitors (RASI) and the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on IgA nephropathy (IgAN) have been reported. However, it is unknown whether these agent
Autor:
Keiko Uchida, Ayami Ochi, Mitsuyo Itabashi, Takashi Takei, Chihiro Iwasaki, Yasuko Oshima, Kayu Tanaka, Takahito Moriyama, Kosaku Nitta, Hiroshi Kataoka
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 3, p e91756 (2014)
PLoS ONE, Vol 9, Iss 3, p e91756 (2014)
BACKGROUND: Little is known about the long-term prognosis of patients with IgA nephropathy (IgAN). METHODS: This retrospective cohort analysis evaluated clinical and histological findings at the time of renal biopsy, initial treatment, patient outcom
Autor:
Takahito Moriyama, Ayami Ochi, Yasuko Oshima, Chihiro Iwasaki, Mitsuyo Itabashi, Kosaku Nitta, Kayu Tanaka, Takashi Takei, Keiko Uchida
Publikováno v:
Renal failure. 36(3)
The renoprotective pleiotropic effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) has recently been reported by several investigators. However, the effect of statins on IgA nephropathy (IgAN) is still unknown.We selected 2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.